GRI Bio, Inc. SEC filings GRI
GRI Bio, Inc. has 402 filings in SEC EDGAR's recent list, going back to Sep 11, 2020. Its latest annual report, Form ARS, was filed on Sep 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jan 30, 2026 | — |
| S-3 | Shelf registration | Jan 30, 2026 | — |
| S-8 | Employee stock plan registration | Jan 30, 2026 | — |
| 424B5 | Prospectus supplement | Jan 9, 2026 | — |
| 424B4 | Prospectus | Dec 12, 2025 | — |
| S-1/A | Amended registration statement | Dec 10, 2025 | — |
| S-1 | Registration statement | Dec 8, 2025 | — |
| 424B3 | Prospectus | Dec 8, 2025 | — |
| 424B3 | Prospectus | Nov 14, 2025 | — |
| 424B3 | Prospectus | Aug 15, 2025 | — |
| S-8 | Employee stock plan registration | Aug 13, 2025 | — |
| 424B5 | Prospectus supplement | May 23, 2025 | — |
| 424B5 | Prospectus supplement | May 5, 2025 | — |
| 424B4 | Prospectus | Apr 2, 2025 | — |
| S-1/A | Amended registration statement | Mar 26, 2025 | — |
| S-1 | Registration statement | Mar 25, 2025 | — |
| S-8 | Employee stock plan registration | Jan 6, 2025 | — |
| 424B5 | Prospectus supplement | Dec 20, 2024 | — |
| 424B3 | Prospectus | Nov 15, 2024 | — |
| S-3 | Shelf registration | Nov 14, 2024 | — |
| 424B3 | Prospectus | Sep 11, 2024 | — |
| 424B3 | Prospectus | Sep 11, 2024 | — |
| 424B3 | Prospectus | Aug 28, 2024 | — |
| 424B3 | Prospectus | Aug 28, 2024 | — |
| 424B3 | Prospectus | Aug 28, 2024 | — |
| 424B5 | Prospectus supplement | Jul 26, 2024 | — |
| 424B5 | Prospectus supplement | Jul 19, 2024 | — |
| 424B4 | Prospectus | Jun 27, 2024 | — |
| S-1/A | Amended registration statement | Jun 26, 2024 | — |
| S-1/A | Amended registration statement | Jun 26, 2024 | — |
| S-1 | Registration statement | Jun 20, 2024 | — |
| 424B3 | Prospectus | Jun 18, 2024 | — |
| 424B3 | Prospectus | Jun 18, 2024 | — |
| 424B3 | Prospectus | Jun 17, 2024 | — |
| 424B3 | Prospectus | Jun 17, 2024 | — |
| 424B3 | Prospectus | May 31, 2024 | — |
| 424B3 | Prospectus | May 31, 2024 | — |
| 424B3 | Prospectus | May 21, 2024 | — |
| 424B3 | Prospectus | May 21, 2024 | — |
| 424B5 | Prospectus supplement | May 20, 2024 | — |
| 424B3 | Prospectus | May 14, 2024 | — |
| 424B3 | Prospectus | May 14, 2024 | — |
| S-3 | Shelf registration | May 10, 2024 | — |
| 424B3 | Prospectus | Mar 28, 2024 | — |
| 424B3 | Prospectus | Mar 28, 2024 | — |
| 424B3 | Prospectus | Feb 2, 2024 | — |
| 424B4 | Prospectus | Feb 2, 2024 | — |
| S-1/A | Amended registration statement | Jan 31, 2024 | — |
| S-1/A | Amended registration statement | Jan 31, 2024 | — |
| 424B3 | Prospectus | Jan 30, 2024 | — |
| 424B3 | Prospectus | Jan 19, 2024 | — |
| 424B3 | Prospectus | Jan 8, 2024 | — |
| S-1 | Registration statement | Dec 21, 2023 | — |
| 424B3 | Prospectus | Dec 15, 2023 | — |
| S-1/A | Amended registration statement | Dec 4, 2023 | — |
| S-3 | Shelf registration | Oct 13, 2023 | — |
| 424B3 | Prospectus | Jun 7, 2023 | — |
| S-3 | Shelf registration | May 30, 2023 | — |
| 424B3 | Prospectus | Apr 21, 2023 | — |
| 424B3 | Prospectus | Apr 7, 2023 | — |
| 424B3 | Prospectus | Mar 31, 2023 | — |
| 424B3 | Prospectus | Mar 8, 2023 | — |
| S-4/A | Filing | Mar 6, 2023 | — |
| S-4/A | Filing | Feb 24, 2023 | — |
| S-4/A | Filing | Feb 9, 2023 | — |
| S-4/A | Filing | Jan 30, 2023 | — |
| S-4 | Registration for a merger or exchange | Dec 23, 2022 | — |
| 424B3 | Prospectus | Jun 8, 2022 | — |
| S-1 | Registration statement | May 27, 2022 | — |
| 424B5 | Prospectus supplement | May 13, 2022 | — |
| 424B3 | Prospectus | May 2, 2022 | — |
| S-3 | Shelf registration | Apr 26, 2022 | — |
| S-8 | Employee stock plan registration | May 10, 2021 | — |
| 424B4 | Prospectus | Feb 11, 2021 | — |
| S-1MEF | Filing | Feb 9, 2021 | — |
| S-1/A | Amended registration statement | Jan 28, 2021 | — |
| FWP | Free writing prospectus | Jan 21, 2021 | — |
| S-1/A | Amended registration statement | Jan 14, 2021 | — |
| S-1/A | Amended registration statement | Nov 16, 2020 | — |
| S-1 | Registration statement | Oct 23, 2020 | — |
Showing 80 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GRI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- La Jolla, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1824293
- Former names
- Vallon Pharmaceuticals, Inc. (until Apr 21, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.